Revised SPC: HyQvia (human normal immunoglobulin) 100 mg/ml solution for infusion for subcutaneous use

The indications have been amended to: 1) Primary immunodeficiency syndromes with impaired antibody production; and 2) Secondary immunodeficiencies in certain patients, with respective changes to posology and method of administration.

Source:

electronic Medicines compendium